Gensight Biologics (France) Analysis
| SIGHT Stock | EUR 0.37 0.05 15.62% |
Gensight Biologics SA is overvalued with Real Value of 0.3 and Hype Value of 0.37. The main objective of Gensight Biologics stock analysis is to determine its intrinsic value, which is an estimate of what Gensight Biologics SA is worth, separate from its market price. There are two main types of Gensight Biologics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Gensight Biologics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Gensight Biologics' stock to identify patterns and trends that may indicate its future price movements.
The Gensight Biologics stock is traded in France on Euronext Paris, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in France. Gensight Biologics is usually not traded on Christmas Day, New Year 's Day, Easter Monday, International Workers ' Day, Victory in Europe Day. Gensight Stock trading window is adjusted to Europe/Paris timezone.
Gensight |
Gensight Stock Analysis Notes
About 13.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.68. Gensight Biologics had not issued any dividends in recent years. GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. GenSight Biologics S.A. was founded in 2012 and is headquartered in Paris, France. GENSIGHT BIOLOGICS is traded on Paris Stock Exchange in France. To find out more about Gensight Biologics SA contact Bernard Gilly at 33 1 76 21 72 20 or learn more at https://www.gensight-biologics.com.Gensight Biologics Investment Alerts
| Gensight Biologics has some characteristics of a very speculative penny stock | |
| Gensight Biologics had very high historical volatility over the last 90 days | |
| The company reported the revenue of 5.28 M. Net Loss for the year was (28.62 M) with profit before overhead, payroll, taxes, and interest of 7.71 M. | |
| Gensight Biologics SA has accumulated about 44.29 M in cash with (17.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.06, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 13.0% of the company outstanding shares are owned by corporate insiders |
Gensight Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 144.58 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Gensight Biologics's market, we take the total number of its shares issued and multiply it by Gensight Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 2nd of December, Gensight Biologics retains the Risk Adjusted Performance of 0.0067, market risk adjusted performance of 1.5, and Standard Deviation of 4.72. Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Gensight Biologics SA, as well as the relationship between them.Gensight Biologics Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Gensight Biologics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Gensight Biologics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Gensight Biologics Outstanding Bonds
Gensight Biologics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Gensight Biologics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Gensight bonds can be classified according to their maturity, which is the date when Gensight Biologics SA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Gensight Biologics Predictive Daily Indicators
Gensight Biologics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Gensight Biologics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Gensight Biologics Forecast Models
Gensight Biologics' time-series forecasting models are one of many Gensight Biologics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Gensight Biologics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Gensight Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Gensight Biologics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Gensight shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Gensight Biologics. By using and applying Gensight Stock analysis, traders can create a robust methodology for identifying Gensight entry and exit points for their positions.
GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. GenSight Biologics S.A. was founded in 2012 and is headquartered in Paris, France. GENSIGHT BIOLOGICS is traded on Paris Stock Exchange in France.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Gensight Biologics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Additional Tools for Gensight Stock Analysis
When running Gensight Biologics' price analysis, check to measure Gensight Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gensight Biologics is operating at the current time. Most of Gensight Biologics' value examination focuses on studying past and present price action to predict the probability of Gensight Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gensight Biologics' price. Additionally, you may evaluate how the addition of Gensight Biologics to your portfolios can decrease your overall portfolio volatility.